Semaglutide should not be used if you or your family has a history of certain thyroid tumors or Multiple Endocrine Neoplasia type2 syndrome
Most recently, in April, CMS rejected Humanas internal administrative appeal to change its rating
The base in step a), step c) and step e) is selected from those described above
"Our nomination provides numerous examples of these risks, including unknown impurities, peptide-related impurities, incorrect strengths, and even instances where no semaglutide was present in the product at all," Novo Nordisk spokesperson Jamie Bennet wrote in an email to NPR
In addition, patients with severe liver, kidney problem, uncontrolled diabetes and thyroid problem would be contraindicated as well